BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 22133794)

  • 41. Scleral patch grafts in the management of uveal and ocular surface tumors.
    Barman M; Finger PT; Milman T
    Ophthalmology; 2012 Dec; 119(12):2631-6. PubMed ID: 22858126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
    Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
    Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eye-wall resection.
    Char DH; Miller T; Crawford JB
    Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conservative resection and adjuvant plaque brachytherapy for early-stage conjunctival melanoma.
    Karim R; Conway RM
    Clin Exp Ophthalmol; 2011; 39(4):293-8. PubMed ID: 21105970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with elevated intraocular pressure in eyes with iris melanoma.
    Shields CL; Materin MA; Shields JA; Gershenbaum E; Singh AD; Smith A
    Br J Ophthalmol; 2001 Jun; 85(6):666-9. PubMed ID: 11371484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
    Wilson MW; Hungerford JL
    Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
    Finger PT; Chin KJ; Duvall G;
    Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapeutic and surgical management of iris melanoma: A review.
    Popovic M; Ahmed IIK; DiGiovanni J; Shields CL
    Surv Ophthalmol; 2017; 62(3):302-311. PubMed ID: 28062196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma.
    Jensen AW; Petersen IA; Kline RW; Stafford SL; Schomberg PJ; Robertson DM
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):101-8. PubMed ID: 16111577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
    Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
    Retina; 2008; 28(7):987-95. PubMed ID: 18698302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Iris melanomas. A retrospective study of 11 patients treated by surgical excision].
    Cardine S; Labetoulle M; Kirsch O; Di Nolfo M; Offret H; Frau E
    J Fr Ophtalmol; 2003 Jan; 26(1):31-7. PubMed ID: 12610407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients.
    Damato B; Lecuona K
    Ophthalmology; 2004 May; 111(5):977-83. PubMed ID: 15121377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histopathology of eyes enucleated after endoresection of choroidal melanoma.
    Hadden PW; Hiscott PS; Damato BE
    Ophthalmology; 2004 Jan; 111(1):154-60. PubMed ID: 14711728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.
    Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):199-205. PubMed ID: 20675066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.